CA2480772C - Accommodative intraocular lens - Google Patents
Accommodative intraocular lens Download PDFInfo
- Publication number
- CA2480772C CA2480772C CA002480772A CA2480772A CA2480772C CA 2480772 C CA2480772 C CA 2480772C CA 002480772 A CA002480772 A CA 002480772A CA 2480772 A CA2480772 A CA 2480772A CA 2480772 C CA2480772 C CA 2480772C
- Authority
- CA
- Canada
- Prior art keywords
- optic
- lens
- socket
- lens system
- locking pin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2/1613—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2/1613—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
- A61F2/1624—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus having adjustable focus; power activated variable focus means, e.g. mechanically or electrically by the ciliary muscle or from the outside
- A61F2/1629—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus having adjustable focus; power activated variable focus means, e.g. mechanically or electrically by the ciliary muscle or from the outside for changing longitudinal position, i.e. along the visual axis when implanted
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2/1613—Intraocular lenses having special lens configurations, e.g. multipart lenses; having particular optical properties, e.g. pseudo-accommodative lenses, lenses having aberration corrections, diffractive lenses, lenses for variably absorbing electromagnetic radiation, lenses having variable focus
- A61F2/1648—Multipart lenses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/14—Eye parts, e.g. lenses, corneal implants; Implanting instruments specially adapted therefor; Artificial eyes
- A61F2/16—Intraocular lenses
- A61F2002/1681—Intraocular lenses having supporting structure for lens, e.g. haptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/0033—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements made by longitudinally pushing a protrusion into a complementary-shaped recess, e.g. held by friction fit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2250/0014—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
- A61F2250/0053—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in optical properties
Abstract
A two-optic accommodative lens system. The first lens (12) has a negative power and is located posteriorly against the posterior capsule. The periphery of the first optic contains a pair of clasps (16). The second optic (14) is located anteriorly to the first optic (12) and is of a positive power. The peripheral edge of the second optic contains a pair of locking arms that fit into the clasps (16) contained on the periphery of the first optic to lock the second optic onto the first optic, but allow for rotation of the arms within the clasps. Hinge structures (18) on the locking arms allow the second optic to move relative to the first optic along the optical axis of the lens system in reaction to movement of the ciliary muscle.
Description
ACCOMMODATIVE INTRAOCULAR LENS
Background of the Invention This invention relates generally to the field of intraocular lenses (IOL) and, more particularly, to accommodative IOLs.
The human eye in its simplest terms functions to provide vision by transmitting light through a clear outer portion called the cornea, and focusing the image by way of a crystalline lens onto a retina. The quality of the focused image depends on many factors including the size and shape of the eye, and the transparency of the cornea and the lens.
When age or disease causes the lens to become less transparent, vision deteriorates io because of the diminished light which can be transmitted to the retina.
This deficiency in the lens of the eye is medically known as a cataract. An accepted treatment for this condition is surgical removal of the lens and replacement of the lens function by an artificial intraocular lens (IOL).
In the United States, the majority of cataractous lenses are removed by a surgical technique called phacoemulsification. During this procedure, an opening is made in the anterior capsule and a thin phacoemulsification cutting tip is inserted into the diseased lens and vibrated ultrasonically. The vibrating cutting tip liquifies or emulsifies the lens so that the lens may be aspirated out of the eye. The diseased lens, once removed, is replaced by an artificial lens.
In the natural lens, bifocality of distance and near vision is provided by a mechanism known as accommodation. The natural lens, early in life, is soft and contained within the capsular bag. The bag is suspended from the ciliary muscle by the zonules.
Relaxation of the ciliary muscle tightens the zonules, and stretches the capsular bag. As a result, the natural lens tends to flatten. Tightening of the ciliary muscle relaxes the tension on the zonules, allowing the capsular bag and the natural lens to assume a more rounded shape. In the way, the natural lens can be focus alternatively on near and far objects.
As the lens ages, it becomes harder and is less able to change shape in reaction to the tightening of the ciliary muscle. This makes it harder for the lens to focus on near objects, a medical condition known as presbyopia. Presbyopia affects nearly all adults over the age of 45 or 50.
Prior to the present invention, when a cataract or other disease required the removal of the natural lens and replacement with an artificial IOL, the IOL
was a monofocal lens, requiring that the patient use a pair of spectacles or contact lenses for near vision. Allergan has been selling a bifocal IOL, the Array lens, for several years, but due to quality issues, this lens has not been widely accepted.
Several designs for accommodative IOLs are being studied. For example, several designs manufactured by C&C Vision are currently undergoing clinical trials.
See U.S. Patent Nos. 6,197,059, 5,674,282, 5,496,366 and 5,476,514 (Cumming).
The lens described in these patents is a single optic lens having flexible haptics that allows the optic to move forward and backward in reaction to movement of the ciliary muscle. Similar designs are described in U.S. Patent No. 6,302,911 Bi (Hanna), 6,261,321 B1 and 6,241,777 B1 (both to Kellan). The amount of movement of the optic in these single-lens systems, however, may be insufficient to allow for a useful range of accommodation. In addition, as described in U.S. Patent Nos.
6,197,059, 5,674,282, 5,496,366 and 5,476,514, the eye must be paralyzed for one to two weeks in order for capsular fibrosis to entrap the lens that thereby provides for a rigid association between the lens and the capsular bag. In addition, the commercial models of these lenses are made from a hydrogel or silicone material. Such materials are not inherently resistive to the formation of posterior capsule opacification ("PCO"). The only treatment for PCO is a capsulotomy using a Nd:YAG laser that vaporizes a portion of the posterior capsule. Such destruction of the posterior capsule may destroy the mechanism of accommodation of these lenses.
There have been some attempts to make a two-optic accommodative lens system. For example, U.S. Patent No. 5,275,623 (Sarfarazi), WIPO Publication No. 00/66037 (Glick, et al.) and WO 01/34067 Al (Bandhauer, et al.) all disclose a two-optic lens system with one optic having a positive power and the other optic having a negative power. The optics are connected by a hinge mechanism that reacts to movement of the ciliary muscle to move the optics closer together or further apart, thereby providing accommodation. In order to provide this "zoom lens" effect, movement of the ciliary muscle must be adequately transmitted to the lens system through the capsular bag, and none of these references disclose a mechanism for ensuring that there is a tight connection between the capsular bag and the lens system. In addition, none of these lenses designs have addressed the problem with PCO noted above.
Therefore, a need continues to exist for a safe and stable accommodative intraocular lens system that provides accommodation over a broad and useful range.
Brief Summary of the Invention The present invention improves upon the prior art by providing a two-optic accommodative lens system. The first lens has a negative power and is located posteriorly against the posterior capsule. The periphery of the first optic contains a pair of clasps.
io The second optic is located anteriorly to the first optic and is of a positive power. The peripheral edge of the second optic contains a pair of locking arms that fit into the clasps contained on the periphery of the first optic to lock the second optic onto the first optic, but allow for rotation of the arms within the clasps. Hinge structures on the locking arms allow the second optic to move relative to the first optic along the optical axis of the lens system in reaction to movement of the ciliary muscle.
Accordingly, one objective of the present invention is to provide a safe and biocompatible intraocular lens.
Another objective of the present invention is to provide a safe and biocompatible intraocular lens that is easily implanted in the posterior chamber.
Still another objective of the present invention is to provide a safe and biocompatible intraocular lens that is stable in the posterior chamber.
Still another objective of the present invention is to provide a safe and biocompatible accommodative lens system.
These and other advantages and objectives of the present invention will become apparent from the detailed description and claims that follow.
Background of the Invention This invention relates generally to the field of intraocular lenses (IOL) and, more particularly, to accommodative IOLs.
The human eye in its simplest terms functions to provide vision by transmitting light through a clear outer portion called the cornea, and focusing the image by way of a crystalline lens onto a retina. The quality of the focused image depends on many factors including the size and shape of the eye, and the transparency of the cornea and the lens.
When age or disease causes the lens to become less transparent, vision deteriorates io because of the diminished light which can be transmitted to the retina.
This deficiency in the lens of the eye is medically known as a cataract. An accepted treatment for this condition is surgical removal of the lens and replacement of the lens function by an artificial intraocular lens (IOL).
In the United States, the majority of cataractous lenses are removed by a surgical technique called phacoemulsification. During this procedure, an opening is made in the anterior capsule and a thin phacoemulsification cutting tip is inserted into the diseased lens and vibrated ultrasonically. The vibrating cutting tip liquifies or emulsifies the lens so that the lens may be aspirated out of the eye. The diseased lens, once removed, is replaced by an artificial lens.
In the natural lens, bifocality of distance and near vision is provided by a mechanism known as accommodation. The natural lens, early in life, is soft and contained within the capsular bag. The bag is suspended from the ciliary muscle by the zonules.
Relaxation of the ciliary muscle tightens the zonules, and stretches the capsular bag. As a result, the natural lens tends to flatten. Tightening of the ciliary muscle relaxes the tension on the zonules, allowing the capsular bag and the natural lens to assume a more rounded shape. In the way, the natural lens can be focus alternatively on near and far objects.
As the lens ages, it becomes harder and is less able to change shape in reaction to the tightening of the ciliary muscle. This makes it harder for the lens to focus on near objects, a medical condition known as presbyopia. Presbyopia affects nearly all adults over the age of 45 or 50.
Prior to the present invention, when a cataract or other disease required the removal of the natural lens and replacement with an artificial IOL, the IOL
was a monofocal lens, requiring that the patient use a pair of spectacles or contact lenses for near vision. Allergan has been selling a bifocal IOL, the Array lens, for several years, but due to quality issues, this lens has not been widely accepted.
Several designs for accommodative IOLs are being studied. For example, several designs manufactured by C&C Vision are currently undergoing clinical trials.
See U.S. Patent Nos. 6,197,059, 5,674,282, 5,496,366 and 5,476,514 (Cumming).
The lens described in these patents is a single optic lens having flexible haptics that allows the optic to move forward and backward in reaction to movement of the ciliary muscle. Similar designs are described in U.S. Patent No. 6,302,911 Bi (Hanna), 6,261,321 B1 and 6,241,777 B1 (both to Kellan). The amount of movement of the optic in these single-lens systems, however, may be insufficient to allow for a useful range of accommodation. In addition, as described in U.S. Patent Nos.
6,197,059, 5,674,282, 5,496,366 and 5,476,514, the eye must be paralyzed for one to two weeks in order for capsular fibrosis to entrap the lens that thereby provides for a rigid association between the lens and the capsular bag. In addition, the commercial models of these lenses are made from a hydrogel or silicone material. Such materials are not inherently resistive to the formation of posterior capsule opacification ("PCO"). The only treatment for PCO is a capsulotomy using a Nd:YAG laser that vaporizes a portion of the posterior capsule. Such destruction of the posterior capsule may destroy the mechanism of accommodation of these lenses.
There have been some attempts to make a two-optic accommodative lens system. For example, U.S. Patent No. 5,275,623 (Sarfarazi), WIPO Publication No. 00/66037 (Glick, et al.) and WO 01/34067 Al (Bandhauer, et al.) all disclose a two-optic lens system with one optic having a positive power and the other optic having a negative power. The optics are connected by a hinge mechanism that reacts to movement of the ciliary muscle to move the optics closer together or further apart, thereby providing accommodation. In order to provide this "zoom lens" effect, movement of the ciliary muscle must be adequately transmitted to the lens system through the capsular bag, and none of these references disclose a mechanism for ensuring that there is a tight connection between the capsular bag and the lens system. In addition, none of these lenses designs have addressed the problem with PCO noted above.
Therefore, a need continues to exist for a safe and stable accommodative intraocular lens system that provides accommodation over a broad and useful range.
Brief Summary of the Invention The present invention improves upon the prior art by providing a two-optic accommodative lens system. The first lens has a negative power and is located posteriorly against the posterior capsule. The periphery of the first optic contains a pair of clasps.
io The second optic is located anteriorly to the first optic and is of a positive power. The peripheral edge of the second optic contains a pair of locking arms that fit into the clasps contained on the periphery of the first optic to lock the second optic onto the first optic, but allow for rotation of the arms within the clasps. Hinge structures on the locking arms allow the second optic to move relative to the first optic along the optical axis of the lens system in reaction to movement of the ciliary muscle.
Accordingly, one objective of the present invention is to provide a safe and biocompatible intraocular lens.
Another objective of the present invention is to provide a safe and biocompatible intraocular lens that is easily implanted in the posterior chamber.
Still another objective of the present invention is to provide a safe and biocompatible intraocular lens that is stable in the posterior chamber.
Still another objective of the present invention is to provide a safe and biocompatible accommodative lens system.
These and other advantages and objectives of the present invention will become apparent from the detailed description and claims that follow.
Brief Description of the Drawing FIG. 1 is an enlarged top plan view of the first optic of a first embodiment of the lens system of the present invention.
FIG. 2 is an enlarged cross-sectional view of the first optic of a first embodiment of the lens system of the present invention taken at line 2-2 in FIG. 1.
FIG. 3 is an enlarged top plan view of the second optic of a first embodiment of the lens system of the present invention.
FIG. 4 is an enlarged cross-sectional view of the second optic of a first embodiment of the lens system of the present invention taken at line 4-4 in FIG. 3.
FIG. 5 is an enlarged partial cross-sectional view taken at circle 5 in FIG.
4.
FIG. 6 is an enlarged top plan view of the first optic of a second embodiment of the lens system of the present invention.
FIG. 7 is an enlarged cross-sectional view of the first optic of a second embodiment of the lens system of the present invention taken at line 7-7 in FIG..6.
FIG. 8 is an enlarged top plan view of the second optic of a second embodiment of the lens system of the present invention.
FIG. 9 is an enlarged cross-sectional view of the second optic of a second embodiment of the lens system of the present invention taken at line 9-9 in FIG. 8.
FIG. 10 is a cross-sectional view of the first embodiment of the lens system of the present invention illustrated in FIGS. 1-5.
FIG. 11 is a cross-sectional view of the second embodiment of the lens system of the present invention illustrated in FIGS. 6-9.
FIG. 12 is a cross-sectional view of the first embodiment of the lens system of the present invention illustrated in FIGS. 1-5 and illustrating the lens system implanted within a capsular bag.
FIG. 13 is a cross-sectional view of the second embodiment of the lens system of the present invention illustrated in FIGS. 6-9 and illustrating the lens system implanted within a capsular bag.
FIG. 14 is an enlarged top plan view of the first optic of a third embodiment of the lens system of the present invention.
FIG. 15 is an enlarged cross-sectional view of the first optic of a third embodiment of the lens system of the present invention taken at line 15-15 in FIG. 14.
FIG. 16 is an enlarged partial cross-sectional view taken at circle 16 in FIG.
15.
FIG. 17 is an enlarged top plan view of the second optic of a third embodiment of 5 the lens system of the present invention.
FIG. 18 is an enlarged cross-sectional view of the second optic of a third embodiment of the lens system of the present invention taken at line 18-18 in FIG. 17.
FIG. 19 is an enlarged partial cross-sectional view taken at circle 19 in FIG.
18.
FIG. 20 is an enlarged top plan view of the third embodiment of the lens system of the present invention illustrated in FIGS. 14-19.
FIG. 21 is a cross-sectional view of the third embodiment of the lens system of the present invention taken at line 21-21 in FIG. 20.
FIG. 22 is an enlarged top plan view of the first optic of a fourth embodiment of the lens system of the present invention.
FIG. 23 is an enlarged cross-sectional view of the first optic of a third embodiment of the lens system of the present invention taken at line 23-23 in FIG. 22. -FIG. 24 is an enlarged top plan view of the second optic of a fourth embodiment of the lens system of the present invention.
FIG. 25 is an enlarged cross-sectional view of the second optic of a third embodiment of the lens system of the present invention taken at line 25-25 in FIG. 24.
FIG. 26 is an enlarged partial cross-sectional view taken at circle 26 in FIG.
25.
FIG. 27 is an enlarged top plan view of the fourth embodiment of the lens system of the present invention illustrated in FIGS. 26-26.
FIG. 28 is a cross-sectional view of the fourth embodiment of the lens system of the present invention taken at line 28-28 in FIG. 27.
Detailed Description of the Invention As best seen in FIGS. 1-5 and 10, lens system 10 of the present invention generally consists of posterior optic 12 and anterior optic 14. Optic 12 is preferably formed in any suitable overall diameter or length, for example, around 12 millimeters, for implantation in the posterior chamber. Optic 12 preferably is made from a soft, foldable material that is inherently resistive to the formation of PCO, such as a soft acrylic. Optic 14 preferable is made from a soft, foldable material such as a hydrogel, silicone or soft acrylic. Optic 12 may be any suitable power, but preferably has a negative power. Optic 14 may also be any suitable power but preferably has a positive power. The relative powers of optics 12 and 14 should be such that the axial movement of optic 14 toward or away from optic 12 should be sufficient to adjust the overall power of lens system 10 at least one diopter and preferably, at least three to four diopters, calculation of such powers of optics 12 and 14 being within the capabilities of one skilled in the art of designing ophthalmic lenses by, for example, using the following equations:
P= P1 + P2 - T/n * P1P2 (1) SP = ST/n PIP2 (2) As best seen in FIGS. 1 and 2, optic 12 is generally symmetrical about optical axis 22 and contains a pair of opposing clasps 16 that are shaped to stretch and fill equatorial region 210 of capsular bag 200. Clasps 16 contain sockets 18 generally defined by latch 20. As best seen in FIGS. 3-5, optic 14 contains a pair of haptics 24 that are connected to optic 14 by hinge regions 26 and contain locking pins 28 distally from hinge regions 26.
As seen in FIG. 10, locking pins 28 are sized and shaped to fit' within sockets 18 on optic 12, thereby holding optic 14 firmly within optic 12 while still permitting rotation of locking pins 28 within sockets 18. One skilled in the art will recognize that sockets 18 may be located on hinge regions 26 and that locking pins 28 may be located on optic 12.
In order to insert locking pins 28 within sockets 18, sockets 18 may be spread apart slightly, thereby preloading haptics 24. Once implanted in an eye, as one skilled in the art will recognize, contraction of capsular bag 200 will cause clasps 16 to collapse slightly, thereby causing compression of optic 14. As optic 14 is compressed, hinge regions 26 allow optic 14 to vault anteriorly away from optic 12, with locking pins 28 pivoting within sockets 18. One skilled in the art will recognize that no specific feature needs to be used to form hinge regions 26 as haptics 24 may be formed from a material and/or in such a configuration that haptics naturally flex in the manner of a hinge.
As best seen in FIGS. 6-9 and 11, lens system 110 of the present invention generally consisting of posterior optic 112 and anterior optic 114. Optic 112 is preferably formed in any suitable overall diameter or length, for example, around 12 millimeters, for implantation in the posterior chamber. Optic 112 preferably is made from a soft, foldable material that is inherently resistive to the formation of PCO, such as a soft acrylic. Optic 114 preferable is made from a soft, foldable material such as a hydrogel, silicone or soft acrylic. Optic 112 may be any suitable power, but preferably has a negative power. Optic 114 may also be any suitable power but preferably has a positive power. The relative powers of optics 112 and 114 should be such that the axial movement of optic 114 toward or away from optic 112 should be sufficient to adjust the overall power of lens system 10 at least one diopter and preferably, at least three to four diopters, calculation of such io powers of optics 112 and 114 being within the capabilities of one skilled in the art. One skilled in the art will also recognize that the axial movement of optic 114 relative to optic 112 is greater in this embodiment as opposed to the embodiment illustrated in FIGS. 1-5 due to the longer length of haptic 124 versus haptic 24.
As best seen in FIGS. 6, 7 and 13, optic 112 is generally symmetrical about optical axis 122 and contains a pair of opposing clasps 116 that are shaped to stretch and fill equatorial region 310 of capsular bag 300. Clasps 116 contain sockets 118 generally defmed by latch 120. As best seen in FIGS. 8 and 9, optic 114 contains circumferential haptic 124 that are connected to optic 114 by hinge regions 126 and contain locking pins 128 distally on the periphery of haptics 124. One skilled in the art will recognize that sockets 118 may be located on clasps 116 and that locking pins 128 may be located on haptics 124. As seen in FIG. 11, locking pins 128 are sized and shaped to fit within sockets 118 on optic 112, thereby holding optic 114 firmly within optic 112 while still permitting rotation of locking pins 128 within sockets 118. Preferably, locking pins 128 are located approximately 90 from hinge regions 126 around the circumference of optic 114. In order to insert locking pins 128 within sockets 118, sockets 118 may be spread apart slightly, thereby preloading haptics 124. One skilled in the art will recognize that no specific feature needs to be used to form hinge regions 126 as haptics 124 may be formed from a material and/or in such a configuration that haptics naturally flex in the manner of a hinge.
Once implanted in an eye, as one skilled in the art will recognize, contraction of capsular bag 300 will cause clasps 116 to collapse slightly, thereby causing compression of optic 114. As optic 114 is compressed, hinge regions 126 allow optic 114 to vault anteriorly away from optic 112, with locking pins 128 pivoting within sockets 118.
As best seen in FIGS. 12 and 13, lens system 10 and 110 fills capsular bag 200 and 300, respectively, following removal of the natural lens. In order to remove the natural lens, an opening or rhexis is normally made in the anterior side of capsule 200 or 300. The opening contains rim or margin 212 or 312 During implantation of system 10 or 110, rim or margin 212 or 312 is inserted into socket 18 or 118 prior to the introduction of optic 14 or 114, respectively. Once optic 14 or 114 is installed in optic 12 or 112, locking pins 28 and 128 help to contain rim 212 or.312 within sockets 18 or 118, respectively, thereby maintaining a positive mechanical connection between capsular bag 200 and 300 and lens system 10 and 110, respectively. Contraction of capsular bag 200 or 300 will therefore be more directly translated into contraction of optics 12 and 112, respectively. In addition, the self-locking design of sockets 18 and 118 prevent capsular bag 200 and 300 from slipping out of sockets 18 or 118, respectively.
As best seen in FIGS. 15-21, lens system 410 of the present invention of the present invention generally consists of posterior optic 412 and anterior optic 414. Optic 412 is preferably formed in any suitable overall diameter or length, for example, around 12 millimeters, for implantation in the posterior chamber. Optic 412 preferably is made from a soft, foldable material that is inherently resistive to the formation of PCO, such as a soft acrylic. Optic 414 preferable is made from a soft, foldable material such as a hydrogel, silicone or soft acrylic. Optic 412 may be any suitable power, but preferably has a iiegative power. Optic 414 may also be any suitable power but preferably has a positive power. The relative powers of optics 412 and 414 should be such that the axial movement of optic 414 toward or away from optic 412 should be sufficient to adjust the overall power of lens system 410 at least one diopter and preferably, at least three to four diopters, calculation of such powers of optics 412 and 414 being within the capabilities of one skilled in the art as described above.
As best seen in FIGS. 15 and 16, optic 412 is generally symmetrical about optical axis 422 and contains a circumferential socket 418. As best seen in FIGS. 17-19, optic 414 contains a pair of hemispherical haptics 424 that are connected to optic 414 by hinge regions 426 and contain circumferential locking rib 428. As seen in FIG. 21, locking rib 428 is sized and shaped to fit within socket 418 on optic 412, thereby holding optic 414 firmly within optic 412 while allowing rotation of locking rib 428 within socket 418.
Once implanted in an eye, as one skilled in the art will recognize, contraction of the capsular bag will cause compression of optic 414. As optic 414 is compressed, hinge regions 426 allow optic 414 to vault anteriorly away from optic 412, with locking rib 428 s pivoting within socket 418.
As best seen in FIGS. 22-28, lens system 510 of the present invention of the present invention is similar to system 510 and generally consists of posterior optic 512 and anterior optic 514. Optic 512 is preferably formed in any suitable overall diameter or length, for example, around 12 millimeters, for implantation in the posterior chamber.
io Optic 512 preferably is made from a soft, foldable material that is inherently resistive to the formation of PCO, such as a soft acrylic. Optic 514 preferable is made from a soft, foldable material such as a hydrogel, silicone or soft acrylic. Optic 512 may be any suitable power, but preferably has a negative power. Optic 514 may also be any suitable power but preferably has a positive power. The relative powers of optics 512 and 514 15 should be such that the axial movement of optic 514 toward or away from optic 512 should be sufficient to adjust the overall power of lens system 510 at least one diopter and preferably, at least three to four diopters, calculation of such powers of optics 512 and 514 being within the capabilities of one skilled in the art as described above.
As best seen in FIGS. 22 and 23, optic 512 is generally symmetrical about optical 20 axis 522 and contains a circumferential rib 528, which is similar to rib 428 in system 410.
As best seen in FIGS. 24-26, optic 514 contains a pair of hemispherical haptics 524 that are connected to optic 514 by hinge regions 526 and contain circumferential socket 518.
As seen in FIG. 28, locking rib 528 is sized and shaped to fit within socket 518 on optic 514, thereby holding optic 514 firmly within optic 512 while allowing rotation of locking a.s rib 528 within socket 518. Once implanted in an eye, as one skilled in the art will recognize, contraction of the capsular bag will cause compression of optic 514. As optic 514 is compressed, hinge regions 526 allow optic 514 to vault anteriorly away from optic 512, with locking rib 528 pivoting within socket 518.
This description is given for purposes of illustration and explanation. It will be 30 apparent to those skilled in the relevant art that changes and modifications may be made to the invention described above without departing from its scope or spirit.
FIG. 2 is an enlarged cross-sectional view of the first optic of a first embodiment of the lens system of the present invention taken at line 2-2 in FIG. 1.
FIG. 3 is an enlarged top plan view of the second optic of a first embodiment of the lens system of the present invention.
FIG. 4 is an enlarged cross-sectional view of the second optic of a first embodiment of the lens system of the present invention taken at line 4-4 in FIG. 3.
FIG. 5 is an enlarged partial cross-sectional view taken at circle 5 in FIG.
4.
FIG. 6 is an enlarged top plan view of the first optic of a second embodiment of the lens system of the present invention.
FIG. 7 is an enlarged cross-sectional view of the first optic of a second embodiment of the lens system of the present invention taken at line 7-7 in FIG..6.
FIG. 8 is an enlarged top plan view of the second optic of a second embodiment of the lens system of the present invention.
FIG. 9 is an enlarged cross-sectional view of the second optic of a second embodiment of the lens system of the present invention taken at line 9-9 in FIG. 8.
FIG. 10 is a cross-sectional view of the first embodiment of the lens system of the present invention illustrated in FIGS. 1-5.
FIG. 11 is a cross-sectional view of the second embodiment of the lens system of the present invention illustrated in FIGS. 6-9.
FIG. 12 is a cross-sectional view of the first embodiment of the lens system of the present invention illustrated in FIGS. 1-5 and illustrating the lens system implanted within a capsular bag.
FIG. 13 is a cross-sectional view of the second embodiment of the lens system of the present invention illustrated in FIGS. 6-9 and illustrating the lens system implanted within a capsular bag.
FIG. 14 is an enlarged top plan view of the first optic of a third embodiment of the lens system of the present invention.
FIG. 15 is an enlarged cross-sectional view of the first optic of a third embodiment of the lens system of the present invention taken at line 15-15 in FIG. 14.
FIG. 16 is an enlarged partial cross-sectional view taken at circle 16 in FIG.
15.
FIG. 17 is an enlarged top plan view of the second optic of a third embodiment of 5 the lens system of the present invention.
FIG. 18 is an enlarged cross-sectional view of the second optic of a third embodiment of the lens system of the present invention taken at line 18-18 in FIG. 17.
FIG. 19 is an enlarged partial cross-sectional view taken at circle 19 in FIG.
18.
FIG. 20 is an enlarged top plan view of the third embodiment of the lens system of the present invention illustrated in FIGS. 14-19.
FIG. 21 is a cross-sectional view of the third embodiment of the lens system of the present invention taken at line 21-21 in FIG. 20.
FIG. 22 is an enlarged top plan view of the first optic of a fourth embodiment of the lens system of the present invention.
FIG. 23 is an enlarged cross-sectional view of the first optic of a third embodiment of the lens system of the present invention taken at line 23-23 in FIG. 22. -FIG. 24 is an enlarged top plan view of the second optic of a fourth embodiment of the lens system of the present invention.
FIG. 25 is an enlarged cross-sectional view of the second optic of a third embodiment of the lens system of the present invention taken at line 25-25 in FIG. 24.
FIG. 26 is an enlarged partial cross-sectional view taken at circle 26 in FIG.
25.
FIG. 27 is an enlarged top plan view of the fourth embodiment of the lens system of the present invention illustrated in FIGS. 26-26.
FIG. 28 is a cross-sectional view of the fourth embodiment of the lens system of the present invention taken at line 28-28 in FIG. 27.
Detailed Description of the Invention As best seen in FIGS. 1-5 and 10, lens system 10 of the present invention generally consists of posterior optic 12 and anterior optic 14. Optic 12 is preferably formed in any suitable overall diameter or length, for example, around 12 millimeters, for implantation in the posterior chamber. Optic 12 preferably is made from a soft, foldable material that is inherently resistive to the formation of PCO, such as a soft acrylic. Optic 14 preferable is made from a soft, foldable material such as a hydrogel, silicone or soft acrylic. Optic 12 may be any suitable power, but preferably has a negative power. Optic 14 may also be any suitable power but preferably has a positive power. The relative powers of optics 12 and 14 should be such that the axial movement of optic 14 toward or away from optic 12 should be sufficient to adjust the overall power of lens system 10 at least one diopter and preferably, at least three to four diopters, calculation of such powers of optics 12 and 14 being within the capabilities of one skilled in the art of designing ophthalmic lenses by, for example, using the following equations:
P= P1 + P2 - T/n * P1P2 (1) SP = ST/n PIP2 (2) As best seen in FIGS. 1 and 2, optic 12 is generally symmetrical about optical axis 22 and contains a pair of opposing clasps 16 that are shaped to stretch and fill equatorial region 210 of capsular bag 200. Clasps 16 contain sockets 18 generally defined by latch 20. As best seen in FIGS. 3-5, optic 14 contains a pair of haptics 24 that are connected to optic 14 by hinge regions 26 and contain locking pins 28 distally from hinge regions 26.
As seen in FIG. 10, locking pins 28 are sized and shaped to fit' within sockets 18 on optic 12, thereby holding optic 14 firmly within optic 12 while still permitting rotation of locking pins 28 within sockets 18. One skilled in the art will recognize that sockets 18 may be located on hinge regions 26 and that locking pins 28 may be located on optic 12.
In order to insert locking pins 28 within sockets 18, sockets 18 may be spread apart slightly, thereby preloading haptics 24. Once implanted in an eye, as one skilled in the art will recognize, contraction of capsular bag 200 will cause clasps 16 to collapse slightly, thereby causing compression of optic 14. As optic 14 is compressed, hinge regions 26 allow optic 14 to vault anteriorly away from optic 12, with locking pins 28 pivoting within sockets 18. One skilled in the art will recognize that no specific feature needs to be used to form hinge regions 26 as haptics 24 may be formed from a material and/or in such a configuration that haptics naturally flex in the manner of a hinge.
As best seen in FIGS. 6-9 and 11, lens system 110 of the present invention generally consisting of posterior optic 112 and anterior optic 114. Optic 112 is preferably formed in any suitable overall diameter or length, for example, around 12 millimeters, for implantation in the posterior chamber. Optic 112 preferably is made from a soft, foldable material that is inherently resistive to the formation of PCO, such as a soft acrylic. Optic 114 preferable is made from a soft, foldable material such as a hydrogel, silicone or soft acrylic. Optic 112 may be any suitable power, but preferably has a negative power. Optic 114 may also be any suitable power but preferably has a positive power. The relative powers of optics 112 and 114 should be such that the axial movement of optic 114 toward or away from optic 112 should be sufficient to adjust the overall power of lens system 10 at least one diopter and preferably, at least three to four diopters, calculation of such io powers of optics 112 and 114 being within the capabilities of one skilled in the art. One skilled in the art will also recognize that the axial movement of optic 114 relative to optic 112 is greater in this embodiment as opposed to the embodiment illustrated in FIGS. 1-5 due to the longer length of haptic 124 versus haptic 24.
As best seen in FIGS. 6, 7 and 13, optic 112 is generally symmetrical about optical axis 122 and contains a pair of opposing clasps 116 that are shaped to stretch and fill equatorial region 310 of capsular bag 300. Clasps 116 contain sockets 118 generally defmed by latch 120. As best seen in FIGS. 8 and 9, optic 114 contains circumferential haptic 124 that are connected to optic 114 by hinge regions 126 and contain locking pins 128 distally on the periphery of haptics 124. One skilled in the art will recognize that sockets 118 may be located on clasps 116 and that locking pins 128 may be located on haptics 124. As seen in FIG. 11, locking pins 128 are sized and shaped to fit within sockets 118 on optic 112, thereby holding optic 114 firmly within optic 112 while still permitting rotation of locking pins 128 within sockets 118. Preferably, locking pins 128 are located approximately 90 from hinge regions 126 around the circumference of optic 114. In order to insert locking pins 128 within sockets 118, sockets 118 may be spread apart slightly, thereby preloading haptics 124. One skilled in the art will recognize that no specific feature needs to be used to form hinge regions 126 as haptics 124 may be formed from a material and/or in such a configuration that haptics naturally flex in the manner of a hinge.
Once implanted in an eye, as one skilled in the art will recognize, contraction of capsular bag 300 will cause clasps 116 to collapse slightly, thereby causing compression of optic 114. As optic 114 is compressed, hinge regions 126 allow optic 114 to vault anteriorly away from optic 112, with locking pins 128 pivoting within sockets 118.
As best seen in FIGS. 12 and 13, lens system 10 and 110 fills capsular bag 200 and 300, respectively, following removal of the natural lens. In order to remove the natural lens, an opening or rhexis is normally made in the anterior side of capsule 200 or 300. The opening contains rim or margin 212 or 312 During implantation of system 10 or 110, rim or margin 212 or 312 is inserted into socket 18 or 118 prior to the introduction of optic 14 or 114, respectively. Once optic 14 or 114 is installed in optic 12 or 112, locking pins 28 and 128 help to contain rim 212 or.312 within sockets 18 or 118, respectively, thereby maintaining a positive mechanical connection between capsular bag 200 and 300 and lens system 10 and 110, respectively. Contraction of capsular bag 200 or 300 will therefore be more directly translated into contraction of optics 12 and 112, respectively. In addition, the self-locking design of sockets 18 and 118 prevent capsular bag 200 and 300 from slipping out of sockets 18 or 118, respectively.
As best seen in FIGS. 15-21, lens system 410 of the present invention of the present invention generally consists of posterior optic 412 and anterior optic 414. Optic 412 is preferably formed in any suitable overall diameter or length, for example, around 12 millimeters, for implantation in the posterior chamber. Optic 412 preferably is made from a soft, foldable material that is inherently resistive to the formation of PCO, such as a soft acrylic. Optic 414 preferable is made from a soft, foldable material such as a hydrogel, silicone or soft acrylic. Optic 412 may be any suitable power, but preferably has a iiegative power. Optic 414 may also be any suitable power but preferably has a positive power. The relative powers of optics 412 and 414 should be such that the axial movement of optic 414 toward or away from optic 412 should be sufficient to adjust the overall power of lens system 410 at least one diopter and preferably, at least three to four diopters, calculation of such powers of optics 412 and 414 being within the capabilities of one skilled in the art as described above.
As best seen in FIGS. 15 and 16, optic 412 is generally symmetrical about optical axis 422 and contains a circumferential socket 418. As best seen in FIGS. 17-19, optic 414 contains a pair of hemispherical haptics 424 that are connected to optic 414 by hinge regions 426 and contain circumferential locking rib 428. As seen in FIG. 21, locking rib 428 is sized and shaped to fit within socket 418 on optic 412, thereby holding optic 414 firmly within optic 412 while allowing rotation of locking rib 428 within socket 418.
Once implanted in an eye, as one skilled in the art will recognize, contraction of the capsular bag will cause compression of optic 414. As optic 414 is compressed, hinge regions 426 allow optic 414 to vault anteriorly away from optic 412, with locking rib 428 s pivoting within socket 418.
As best seen in FIGS. 22-28, lens system 510 of the present invention of the present invention is similar to system 510 and generally consists of posterior optic 512 and anterior optic 514. Optic 512 is preferably formed in any suitable overall diameter or length, for example, around 12 millimeters, for implantation in the posterior chamber.
io Optic 512 preferably is made from a soft, foldable material that is inherently resistive to the formation of PCO, such as a soft acrylic. Optic 514 preferable is made from a soft, foldable material such as a hydrogel, silicone or soft acrylic. Optic 512 may be any suitable power, but preferably has a negative power. Optic 514 may also be any suitable power but preferably has a positive power. The relative powers of optics 512 and 514 15 should be such that the axial movement of optic 514 toward or away from optic 512 should be sufficient to adjust the overall power of lens system 510 at least one diopter and preferably, at least three to four diopters, calculation of such powers of optics 512 and 514 being within the capabilities of one skilled in the art as described above.
As best seen in FIGS. 22 and 23, optic 512 is generally symmetrical about optical 20 axis 522 and contains a circumferential rib 528, which is similar to rib 428 in system 410.
As best seen in FIGS. 24-26, optic 514 contains a pair of hemispherical haptics 524 that are connected to optic 514 by hinge regions 526 and contain circumferential socket 518.
As seen in FIG. 28, locking rib 528 is sized and shaped to fit within socket 518 on optic 514, thereby holding optic 514 firmly within optic 512 while allowing rotation of locking a.s rib 528 within socket 518. Once implanted in an eye, as one skilled in the art will recognize, contraction of the capsular bag will cause compression of optic 514. As optic 514 is compressed, hinge regions 526 allow optic 514 to vault anteriorly away from optic 512, with locking rib 528 pivoting within socket 518.
This description is given for purposes of illustration and explanation. It will be 30 apparent to those skilled in the relevant art that changes and modifications may be made to the invention described above without departing from its scope or spirit.
Claims (11)
1. An intraocular lens, comprising:
a) a first optic having a clasp with a socket, the socket being defined by a latch;
b) a second optic having at least one haptic, the haptic being made from a hydrogel, a silicone or a soft acrylic and being connected to the second optic by a hinge region; and c) a locking pin located on the haptic, the locking pin sized and shaped to be received in the socket and retained in the socket by the latch and thereby movably attach the second optic to the first optic.
a) a first optic having a clasp with a socket, the socket being defined by a latch;
b) a second optic having at least one haptic, the haptic being made from a hydrogel, a silicone or a soft acrylic and being connected to the second optic by a hinge region; and c) a locking pin located on the haptic, the locking pin sized and shaped to be received in the socket and retained in the socket by the latch and thereby movably attach the second optic to the first optic.
2. The lens of claim 1, wherein the first optic and the second optic comprise a soft acrylic.
3. The lens of claim 1, wherein the second optic comprises a hydrogel.
4. The lens of claim 1, wherein the second optic comprises silicone.
5. The lens of claim 1, wherein the locking pin and socket are sized and shaped to retain an anterior capsular rhexis rim when the locking pin is installed within the socket.
6. The lens of claim 1 wherein the second optic has a circumference and the locking pin is located approximately 90° around the circumference from the hinge region.
7. An intraocular lens, comprising:
a) a first optic having a clasp with a socket, the socket being defined by a latch;
b) a second optic having at least one haptic, the haptic being made from a hydrogel, a silicone or a soft acrylic and being hingedly connected to the second optic; and c) a locking pin located on the haptic, the locking pin sized and shaped to be received in the socket and retained in the socket by the latch and thereby movably attach the second optic to the first optic.
a) a first optic having a clasp with a socket, the socket being defined by a latch;
b) a second optic having at least one haptic, the haptic being made from a hydrogel, a silicone or a soft acrylic and being hingedly connected to the second optic; and c) a locking pin located on the haptic, the locking pin sized and shaped to be received in the socket and retained in the socket by the latch and thereby movably attach the second optic to the first optic.
8. The lens of claim 7, wherein the first optic and the second optic comprise a soft acrylic.
9. The lens of claim 7, wherein the second optic comprises a hydrogel.
10. The lens of claim 7, wherein the second optic comprises silicone.
11. The lens of claim 7, wherein the locking pin and socket are sized and shaped to retain an anterior capsular rhexis rim when the locking pin is installed within the socket.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/134,877 US6695881B2 (en) | 2002-04-29 | 2002-04-29 | Accommodative intraocular lens |
US10/134,877 | 2002-04-29 | ||
PCT/US2003/007249 WO2003092552A1 (en) | 2002-04-29 | 2003-03-07 | Accommodative intraocular lens |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2480772A1 CA2480772A1 (en) | 2003-11-13 |
CA2480772C true CA2480772C (en) | 2008-11-25 |
Family
ID=29249324
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002480772A Expired - Fee Related CA2480772C (en) | 2002-04-29 | 2003-03-07 | Accommodative intraocular lens |
Country Status (13)
Country | Link |
---|---|
US (3) | US6695881B2 (en) |
EP (1) | EP1499264B1 (en) |
JP (1) | JP4242829B2 (en) |
AT (1) | ATE336966T1 (en) |
AU (1) | AU2003220130B2 (en) |
BR (1) | BR0309586A (en) |
CA (1) | CA2480772C (en) |
DE (1) | DE60307816T2 (en) |
DK (1) | DK1499264T3 (en) |
ES (1) | ES2269998T3 (en) |
MX (1) | MXPA04010096A (en) |
PT (1) | PT1499264E (en) |
WO (1) | WO2003092552A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11357620B1 (en) | 2021-09-10 | 2022-06-14 | California LASIK & Eye, Inc. | Exchangeable optics and therapeutics |
Families Citing this family (171)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060149369A1 (en) * | 1997-05-20 | 2006-07-06 | C&C Vision International Limited | Accommodating arching lens |
US20060238702A1 (en) * | 1999-04-30 | 2006-10-26 | Advanced Medical Optics, Inc. | Ophthalmic lens combinations |
US20030060881A1 (en) * | 1999-04-30 | 2003-03-27 | Advanced Medical Optics, Inc. | Intraocular lens combinations |
US7780729B2 (en) | 2004-04-16 | 2010-08-24 | Visiogen, Inc. | Intraocular lens |
US6786934B2 (en) | 2001-01-25 | 2004-09-07 | Visiogen, Inc. | Biasing element for intraocular lens system |
US6884261B2 (en) | 2001-01-25 | 2005-04-26 | Visiogen, Inc. | Method of preparing an intraocular lens for implantation |
US20030078657A1 (en) | 2001-01-25 | 2003-04-24 | Gholam-Reza Zadno-Azizi | Materials for use in accommodating intraocular lens system |
US8062361B2 (en) | 2001-01-25 | 2011-11-22 | Visiogen, Inc. | Accommodating intraocular lens system with aberration-enhanced performance |
US20030078658A1 (en) * | 2001-01-25 | 2003-04-24 | Gholam-Reza Zadno-Azizi | Single-piece accomodating intraocular lens system |
US20120016349A1 (en) | 2001-01-29 | 2012-01-19 | Amo Development, Llc. | Hybrid ophthalmic interface apparatus and method of interfacing a surgical laser with an eye |
US20030060878A1 (en) * | 2001-08-31 | 2003-03-27 | Shadduck John H. | Intraocular lens system and method for power adjustment |
US7763069B2 (en) | 2002-01-14 | 2010-07-27 | Abbott Medical Optics Inc. | Accommodating intraocular lens with outer support structure |
US7150759B2 (en) * | 2002-01-14 | 2006-12-19 | Advanced Medical Optics, Inc. | Multi-mechanistic accommodating intraocular lenses |
US20070100445A1 (en) * | 2003-02-03 | 2007-05-03 | Shadduck John H | Intraocular lenses and business methods |
US7261737B2 (en) * | 2002-12-12 | 2007-08-28 | Powervision, Inc. | Accommodating intraocular lens system and method |
US20050021139A1 (en) * | 2003-02-03 | 2005-01-27 | Shadduck John H. | Ophthalmic devices, methods of use and methods of fabrication |
US8048155B2 (en) | 2002-02-02 | 2011-11-01 | Powervision, Inc. | Intraocular implant devices |
US6935743B2 (en) * | 2002-02-06 | 2005-08-30 | John H. Shadduck | Adaptive optic lens and method of making |
US6695881B2 (en) * | 2002-04-29 | 2004-02-24 | Alcon, Inc. | Accommodative intraocular lens |
US6966649B2 (en) * | 2002-08-12 | 2005-11-22 | John H Shadduck | Adaptive optic lens system and method of use |
US6972033B2 (en) * | 2002-08-26 | 2005-12-06 | Advanced Medical Optics, Inc. | Accommodating intraocular lens assembly with multi-functional capsular bag ring |
US20040082995A1 (en) * | 2002-10-25 | 2004-04-29 | Randall Woods | Telescopic intraocular lens implant for treating age-related macular degeneration |
US7125422B2 (en) * | 2002-10-25 | 2006-10-24 | Quest Vision Technology, Inc. | Accommodating intraocular lens implant |
US20040082993A1 (en) | 2002-10-25 | 2004-04-29 | Randall Woods | Capsular intraocular lens implant having a refractive liquid therein |
US7662180B2 (en) | 2002-12-05 | 2010-02-16 | Abbott Medical Optics Inc. | Accommodating intraocular lens and method of manufacture thereof |
CA2507694C (en) * | 2002-12-12 | 2012-07-31 | Victor Esch | Accommodating intraocular lens system and method |
US8361145B2 (en) | 2002-12-12 | 2013-01-29 | Powervision, Inc. | Accommodating intraocular lens system having circumferential haptic support and method |
US7637947B2 (en) * | 2002-12-12 | 2009-12-29 | Powervision, Inc. | Accommodating intraocular lens system having spherical aberration compensation and method |
EP1569581A4 (en) * | 2002-12-12 | 2006-09-20 | Powervision | Lens system for power adjustment using micropumps |
US8328869B2 (en) | 2002-12-12 | 2012-12-11 | Powervision, Inc. | Accommodating intraocular lenses and methods of use |
US7247168B2 (en) * | 2002-12-12 | 2007-07-24 | Powervision, Inc. | Accommodating intraocular lens system and method |
US7217288B2 (en) * | 2002-12-12 | 2007-05-15 | Powervision, Inc. | Accommodating intraocular lens having peripherally actuated deflectable surface and method |
US10835373B2 (en) | 2002-12-12 | 2020-11-17 | Alcon Inc. | Accommodating intraocular lenses and methods of use |
US6616691B1 (en) * | 2003-01-10 | 2003-09-09 | Alcon, Inc. | Accommodative intraocular lens |
US7238201B2 (en) | 2003-02-13 | 2007-07-03 | Visiogen, Inc. | Accommodating intraocular lens system with enhanced range of motion |
US7029497B2 (en) * | 2003-05-21 | 2006-04-18 | Alcon, Inc. | Accommodative intraocular lens |
US20050125058A1 (en) * | 2003-12-03 | 2005-06-09 | Eyeonics, Inc. | Accommodating hybrid intraocular lens |
AU2004297967C1 (en) * | 2003-12-05 | 2011-10-27 | Innolene Llc | Improved ocular lens |
AU2004296205B2 (en) * | 2003-12-05 | 2009-11-12 | Innfocus, Llc | Glaucoma implant device |
US20050131535A1 (en) * | 2003-12-15 | 2005-06-16 | Randall Woods | Intraocular lens implant having posterior bendable optic |
US7655340B2 (en) * | 2004-01-16 | 2010-02-02 | Gm Global Technology Operations, Inc. | Ultra short high pressure gradient flow path flow field |
US7300464B2 (en) * | 2004-09-30 | 2007-11-27 | Alcon, Inc. | Intraocular lens |
US9872763B2 (en) | 2004-10-22 | 2018-01-23 | Powervision, Inc. | Accommodating intraocular lenses |
US8377123B2 (en) | 2004-11-10 | 2013-02-19 | Visiogen, Inc. | Method of implanting an intraocular lens |
US8579970B1 (en) | 2005-06-27 | 2013-11-12 | Visiogen, Inc. | Magnifying intraocular lens |
US7591849B2 (en) | 2005-07-01 | 2009-09-22 | Bausch & Lomb Incorpoted | Multi-component accommodative intraocular lens with compressible haptic |
US20070016293A1 (en) * | 2005-07-18 | 2007-01-18 | Alcon, Inc. | Accommodative intraocular lens system |
US20070032868A1 (en) * | 2005-08-08 | 2007-02-08 | Randall Woods | Capsular shape-restoring device |
US7316713B2 (en) * | 2005-08-29 | 2008-01-08 | Alcon, Inc. | Accommodative intraocular lens system |
US9629712B2 (en) * | 2005-09-01 | 2017-04-25 | Donald C. Stenger | Accommodating intraocular lens |
US9636213B2 (en) | 2005-09-30 | 2017-05-02 | Abbott Medical Optics Inc. | Deformable intraocular lenses and lens systems |
US20070088433A1 (en) * | 2005-10-17 | 2007-04-19 | Powervision | Accommodating intraocular lens system utilizing direct force transfer from zonules and method of use |
US8241355B2 (en) * | 2005-10-28 | 2012-08-14 | Abbott Medical Optics Inc. | Haptic for accommodating intraocular lens |
US7985253B2 (en) * | 2005-12-07 | 2011-07-26 | C&C Vision International Limited | Hydrolic accommodating intraocular lens |
US20070182917A1 (en) * | 2006-02-09 | 2007-08-09 | Alcon Manufacturing, Ltd. | Intra-ocular device with multiple focusing powers/optics |
US20070260308A1 (en) * | 2006-05-02 | 2007-11-08 | Alcon, Inc. | Accommodative intraocular lens system |
US7918886B2 (en) * | 2006-05-25 | 2011-04-05 | Visioncare Ophthalmic Technologies Inc. | Double insertion intraocular implant |
US20070282438A1 (en) * | 2006-05-31 | 2007-12-06 | Xin Hong | Intraocular lenses with enhanced off-axis visual performance |
US8163015B2 (en) * | 2006-07-25 | 2012-04-24 | C&C Vision International Limited | “W” accommodating intraocular lens |
US20080051886A1 (en) * | 2006-08-24 | 2008-02-28 | Lin J T | Method and device for vision correction via dual-optics accommodating intraocular lens |
US8888845B2 (en) * | 2006-10-20 | 2014-11-18 | Bausch & Lomb Incorporated | Method of inserting an intraocular lens |
CA2673388C (en) | 2006-12-22 | 2015-11-24 | Amo Groningen B.V. | Accommodating intraocular lens, lens system and frame therefor |
CA2674018C (en) | 2006-12-29 | 2015-05-26 | Advanced Medical Optics, Inc. | Multifocal accommodating intraocular lens |
US7713299B2 (en) | 2006-12-29 | 2010-05-11 | Abbott Medical Optics Inc. | Haptic for accommodating intraocular lens |
US20080161914A1 (en) | 2006-12-29 | 2008-07-03 | Advanced Medical Optics, Inc. | Pre-stressed haptic for accommodating intraocular lens |
US20080161912A1 (en) * | 2007-01-02 | 2008-07-03 | Alcon, Inc. | Intraocular Lens |
US8066769B2 (en) * | 2007-01-29 | 2011-11-29 | Werblin Research & Development Corp. | Intraocular lens system |
US8066768B2 (en) * | 2007-01-29 | 2011-11-29 | Werblin Research & Development Corp. | Intraocular lens system |
US7811320B2 (en) * | 2007-01-29 | 2010-10-12 | Werblin Research & Development Corp. | Intraocular lens system |
US9398949B2 (en) * | 2007-01-29 | 2016-07-26 | Emmetropia, Inc. | Intraocular lens system |
US20080306587A1 (en) * | 2007-02-21 | 2008-12-11 | Jingjong Your | Lens Material and Methods of Curing with UV Light |
WO2008103798A2 (en) * | 2007-02-21 | 2008-08-28 | Powervision, Inc. | Polymeric materials suitable for ophthalmic devices and methods of manufacture |
KR100807940B1 (en) * | 2007-03-08 | 2008-02-28 | 박경진 | Intraocular lens |
KR100807939B1 (en) * | 2007-03-08 | 2008-02-28 | 박경진 | Lens assembly |
US20080281415A1 (en) * | 2007-03-13 | 2008-11-13 | C&C Vision International Limited | Second elastic hinge accommodating intraocular lens |
US20090005866A1 (en) * | 2007-03-13 | 2009-01-01 | C&C Vision International Limited | First elastic hinge accommodating intraocular lens |
US8314927B2 (en) | 2007-07-23 | 2012-11-20 | Powervision, Inc. | Systems and methods for testing intraocular lenses |
US8968396B2 (en) | 2007-07-23 | 2015-03-03 | Powervision, Inc. | Intraocular lens delivery systems and methods of use |
US8668734B2 (en) | 2010-07-09 | 2014-03-11 | Powervision, Inc. | Intraocular lens delivery devices and methods of use |
EP2647353B1 (en) * | 2007-07-23 | 2014-12-31 | PowerVision, Inc. | Lens delivery system |
WO2009015226A2 (en) | 2007-07-23 | 2009-01-29 | Powervision, Inc. | Accommodating intraocular lenses and methods of use |
EP2178462B1 (en) * | 2007-07-23 | 2014-04-02 | PowerVision, Inc. | Post-implant lens power modification |
US8414646B2 (en) | 2007-12-27 | 2013-04-09 | Forsight Labs, Llc | Intraocular, accommodating lens and methods of use |
US8167941B2 (en) | 2008-01-03 | 2012-05-01 | Forsight Labs, Llc | Intraocular, accommodating lens and methods of use |
US8034108B2 (en) | 2008-03-28 | 2011-10-11 | Abbott Medical Optics Inc. | Intraocular lens having a haptic that includes a cap |
US20100131060A1 (en) * | 2008-11-20 | 2010-05-27 | Simpson Michael J | Diffractive multifocal intraocular lens with modified central distance zone |
AU2009319753B2 (en) * | 2008-11-26 | 2013-11-14 | Anew Iol Technologies, Inc. | Haptic devices for intraocular lens |
US8216307B2 (en) * | 2008-12-19 | 2012-07-10 | Novartis Ag | Radially segmented apodized diffractive multifocal design for ocular implant |
US10299913B2 (en) | 2009-01-09 | 2019-05-28 | Powervision, Inc. | Accommodating intraocular lenses and methods of use |
EP2384167A4 (en) * | 2009-01-09 | 2016-02-17 | Powervision Inc | Intraocular lenses and methods of accounting for capsule size variability and post-implant changes in the eye |
WO2010093548A1 (en) * | 2009-02-10 | 2010-08-19 | Alcon, Inc. | Accommodative intraocular lens system |
US9078744B2 (en) * | 2009-02-11 | 2015-07-14 | Novartis Ag | Single optic accommodative intraocular lens system |
AU2010266022B2 (en) | 2009-06-26 | 2015-04-23 | Johnson & Johnson Surgical Vision, Inc. | Accommodating intraocular lenses |
WO2011017322A1 (en) | 2009-08-03 | 2011-02-10 | Abbott Medical Optics Inc. | Intraocular lens for providing accomodative vision |
US8447086B2 (en) | 2009-08-31 | 2013-05-21 | Powervision, Inc. | Lens capsule size estimation |
US20110071628A1 (en) * | 2009-09-24 | 2011-03-24 | Rainbow Medical Ltd. | Accommodative intraocular lens |
EP2493421B1 (en) * | 2009-10-26 | 2016-01-06 | Novartis AG | Phase-shifted center-distance diffractive design for ocular implant |
BR112012014939A2 (en) * | 2009-12-18 | 2016-03-08 | Novartis Ag | intraocular devices and associated methods |
JP2013520291A (en) | 2010-02-23 | 2013-06-06 | パワーヴィジョン・インコーポレーテッド | Liquid for accommodation type intraocular lens |
EP2563275A4 (en) | 2010-04-27 | 2017-11-22 | Lensgen, Inc | Accommodating intraocular lens device |
US10278810B2 (en) | 2010-04-29 | 2019-05-07 | Ojo, Llc | Injectable physiologically adaptive intraocular lenses (IOL's) |
US9220590B2 (en) | 2010-06-10 | 2015-12-29 | Z Lens, Llc | Accommodative intraocular lens and method of improving accommodation |
US9351825B2 (en) | 2013-12-30 | 2016-05-31 | James Stuart Cumming | Semi-flexible posteriorly vaulted acrylic intraocular lens for the treatment of presbyopia |
US9295544B2 (en) | 2012-06-05 | 2016-03-29 | James Stuart Cumming | Intraocular lens |
US9295545B2 (en) | 2012-06-05 | 2016-03-29 | James Stuart Cumming | Intraocular lens |
US9585745B2 (en) | 2010-06-21 | 2017-03-07 | James Stuart Cumming | Foldable intraocular lens with rigid haptics |
US10736732B2 (en) | 2010-06-21 | 2020-08-11 | James Stuart Cumming | Intraocular lens with longitudinally rigid plate haptic |
US9918830B2 (en) | 2010-06-21 | 2018-03-20 | James Stuart Cumming | Foldable intraocular lens with rigid haptics |
US8734512B2 (en) | 2011-05-17 | 2014-05-27 | James Stuart Cumming | Biased accommodating intraocular lens |
US8523942B2 (en) | 2011-05-17 | 2013-09-03 | James Stuart Cumming | Variable focus intraocular lens |
US9295546B2 (en) | 2013-09-24 | 2016-03-29 | James Stuart Cumming | Anterior capsule deflector ridge |
WO2012129407A2 (en) | 2011-03-24 | 2012-09-27 | Powervision, Inc. | Intraocular lens loading systems and methods of use |
US10433949B2 (en) | 2011-11-08 | 2019-10-08 | Powervision, Inc. | Accommodating intraocular lenses |
US9364316B1 (en) | 2012-01-24 | 2016-06-14 | Clarvista Medical, Inc. | Modular intraocular lens designs, tools and methods |
US10080648B2 (en) | 2012-01-24 | 2018-09-25 | Clarvista Medical, Inc. | Modular intraocular lens designs, tools and methods |
CA3177993A1 (en) | 2012-01-24 | 2013-08-01 | The Regents Of The University Of Colorado, A Body Corporate | Modular intraocular lens designs and methods |
US10028824B2 (en) | 2012-01-24 | 2018-07-24 | Clarvista Medical, Inc. | Modular intraocular lens designs, tools and methods |
US8900300B1 (en) | 2012-02-22 | 2014-12-02 | Omega Ophthalmics Llc | Prosthetic capsular bag and method of inserting the same |
EP2838472B1 (en) * | 2012-04-20 | 2020-09-23 | Hanita Lenses R.C.A. Ltd. | Intraocular assembly |
US9084674B2 (en) | 2012-05-02 | 2015-07-21 | Abbott Medical Optics Inc. | Intraocular lens with shape changing capability to provide enhanced accomodation and visual acuity |
US20130304206A1 (en) * | 2012-05-10 | 2013-11-14 | Ioannis Pallikaris | Intraocular Device to Restore Natural Capsular Tension after Cataract Surgery |
US9364318B2 (en) | 2012-05-10 | 2016-06-14 | Z Lens, Llc | Accommodative-disaccommodative intraocular lens |
US9925039B2 (en) | 2012-12-26 | 2018-03-27 | Rainbow Medical Ltd. | Accommodative intraocular lens |
US10258462B2 (en) * | 2012-12-26 | 2019-04-16 | Rainbow Medical Ltd. | Accommodative intraocular lens |
US9486311B2 (en) | 2013-02-14 | 2016-11-08 | Shifamed Holdings, Llc | Hydrophilic AIOL with bonding |
US20140330375A1 (en) * | 2013-03-11 | 2014-11-06 | Sean J. McCafferty | Accommodating intraocular lens system with mutually-deforming opposing surfaces |
EP3785668A1 (en) | 2013-03-15 | 2021-03-03 | Alcon Inc. | Intraocular lens storage and loading devices and methods of use |
US10195018B2 (en) | 2013-03-21 | 2019-02-05 | Shifamed Holdings, Llc | Accommodating intraocular lens |
EP2976042B1 (en) | 2013-03-21 | 2023-09-13 | Shifamed Holdings, LLC | Accommodating intraocular lens |
EP2851038A1 (en) | 2013-09-24 | 2015-03-25 | Consejo Superior De Investigaciones Cientificas | Intraocular lens with accomodation capacity |
WO2015066502A1 (en) | 2013-11-01 | 2015-05-07 | Thomas Silvestrini | Accomodating intraocular lens device |
EP3062742B1 (en) | 2013-11-01 | 2021-12-01 | Lensgen, Inc. | Two-part accommodating intraocular lens device |
US9615916B2 (en) | 2013-12-30 | 2017-04-11 | James Stuart Cumming | Intraocular lens |
EP3107510B1 (en) | 2014-02-18 | 2023-04-19 | Alcon Inc. | Apparatus for the removal of an intraocular lens |
CA2952809C (en) * | 2014-06-19 | 2019-11-26 | Omega Ophthalmics Llc | Prosthetic capsular devices, systems, and methods |
US10004596B2 (en) | 2014-07-31 | 2018-06-26 | Lensgen, Inc. | Accommodating intraocular lens device |
CN110279494B (en) | 2014-08-26 | 2023-02-17 | 施菲姆德控股有限责任公司 | Accommodating intraocular lens |
US10299910B2 (en) | 2014-09-22 | 2019-05-28 | Kevin J. Cady | Intraocular pseudophakic contact lens with mechanism for securing by anterior leaflet of capsular wall and related system and method |
US10159562B2 (en) | 2014-09-22 | 2018-12-25 | Kevin J. Cady | Intraocular pseudophakic contact lenses and related systems and methods |
US10945832B2 (en) | 2014-09-22 | 2021-03-16 | Onpoint Vision, Inc. | Intraocular pseudophakic contact lens with mechanism for securing by anterior leaflet of capsular wall and related system and method |
US11109957B2 (en) | 2014-09-22 | 2021-09-07 | Onpoint Vision, Inc. | Intraocular pseudophakic contact lens with mechanism for securing by anterior leaflet of capsular wall and related system and method |
EP3197462A4 (en) | 2014-09-23 | 2018-05-30 | Lensgen, Inc | Polymeric material for accommodating intraocular lenses |
EP3250152A1 (en) | 2015-01-30 | 2017-12-06 | Clarvista Medical, Inc. | Modular intraocular lens designs |
US9358103B1 (en) | 2015-02-10 | 2016-06-07 | Omega Ophthalmics Llc | Prosthetic capsular devices, systems, and methods |
ES2686472T3 (en) | 2015-03-10 | 2018-10-18 | Consejo Superior De Investigaciones Científicas | Photochemically induced coupling of intraocular implants |
AU2016349363B2 (en) | 2015-11-04 | 2022-01-27 | Alcon Inc. | Modular intraocular lens designs, tools and methods |
WO2017079733A1 (en) | 2015-11-06 | 2017-05-11 | Powervision, Inc. | Accommodating intraocular lenses and methods of manufacturing |
US11141263B2 (en) * | 2015-11-18 | 2021-10-12 | Shifamed Holdings, Llc | Multi-piece accommodating intraocular lens |
WO2017096087A1 (en) | 2015-12-01 | 2017-06-08 | Daniel Brady | Accommodating intraocular lens device |
US11045309B2 (en) | 2016-05-05 | 2021-06-29 | The Regents Of The University Of Colorado | Intraocular lens designs for improved stability |
IL245775A0 (en) | 2016-05-22 | 2016-08-31 | Joshua Ben Nun | Hybrid accommodating intraocular lens |
JP2019519664A (en) | 2016-05-27 | 2019-07-11 | レンズジェン、インコーポレイテッド | Narrow molecular weight distribution lens oil for intraocular lens devices |
US10327886B2 (en) * | 2016-06-01 | 2019-06-25 | Rainbow Medical Ltd. | Accomodative intraocular lens |
CA3026494C (en) | 2016-06-06 | 2022-06-07 | Omega Ophthalmics Llc | Prosthetic capsular devices, systems, and methods |
JP7074960B2 (en) | 2016-08-24 | 2022-05-25 | カール ツァイス メディテック アーゲー | Dual Mode Adjustable-Non-Adjustable Intraocular Lens |
EP3954326A1 (en) | 2016-10-21 | 2022-02-16 | Omega Ophthalmics LLC | Prosthetic capsular device |
US10350056B2 (en) | 2016-12-23 | 2019-07-16 | Shifamed Holdings, Llc | Multi-piece accommodating intraocular lenses and methods for making and using same |
US10441411B2 (en) | 2016-12-29 | 2019-10-15 | Rainbow Medical Ltd. | Accommodative intraocular lens |
US10966819B2 (en) * | 2017-05-29 | 2021-04-06 | Rxsight, Inc. | Composite light adjustable intraocular lens |
WO2018222579A1 (en) | 2017-05-30 | 2018-12-06 | Shifamed Holdings, Llc | Surface treatments for accommodating intraocular lenses and associated methods and devices |
EP3634309B1 (en) | 2017-06-07 | 2023-05-24 | Shifamed Holdings, LLC | Adjustable optical power intraocular lenses |
US11382736B2 (en) | 2017-06-27 | 2022-07-12 | Alcon Inc. | Injector, intraocular lens system, and related methods |
AU2018330604A1 (en) | 2017-09-11 | 2020-04-02 | Amo Groningen B.V. | Methods and apparatuses to increase intraocular lenses positional stability |
AU2019249216A1 (en) | 2018-04-06 | 2020-10-01 | Omega Ophthalmics Llc | Prosthetic capsular devices, systems, and methods |
GB2578639A (en) | 2018-11-02 | 2020-05-20 | Rayner Intraocular Lenses Ltd | Hybrid accommodating intraocular lens assemblages including discrete lens unit with segmented lens haptics |
DE202019104086U1 (en) | 2019-07-24 | 2019-08-19 | Valentin Videa | Accommodative intraocular lens |
AU2020357870A1 (en) | 2019-10-04 | 2022-04-28 | Alcon Inc. | Adjustable intraocular lenses and methods of post-operatively adjusting intraocular lenses |
JP2023518570A (en) | 2020-03-27 | 2023-05-02 | アルコン インコーポレイティド | Modular IOL design |
DE102020123518B3 (en) | 2020-09-09 | 2021-09-16 | Carl Zeiss Meditec Ag | Accommodation intraocular lens |
WO2022082170A1 (en) | 2020-10-12 | 2022-04-21 | Omega Ophthalmics Llc | Prosthetic capsular devices, systems, and methods |
DE102021125295B3 (en) * | 2021-09-29 | 2022-11-03 | Carl Zeiss Meditec Ag | ACCOMMODATIVE INTRAOCULAR LENS TO GENERATE A RESTORING FORCE |
Family Cites Families (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4718904A (en) | 1986-01-15 | 1988-01-12 | Eye Technology, Inc. | Intraocular lens for capsular bag implantation |
JP2718961B2 (en) | 1988-11-04 | 1998-02-25 | 株式会社メニコン | Intraocular lens |
US4946469A (en) | 1989-04-20 | 1990-08-07 | Faezeh Sarfarazi | Intraocular lens |
US6197059B1 (en) * | 1990-04-27 | 2001-03-06 | Medevec Licensing, B.V. | Accomodating intraocular lens |
US5476514A (en) | 1990-04-27 | 1995-12-19 | Cumming; J. Stuart | Accommodating intraocular lens |
US5326347A (en) * | 1991-08-12 | 1994-07-05 | Cumming J Stuart | Intraocular implants |
US5578081A (en) | 1991-11-12 | 1996-11-26 | Henry H. McDonald | Eye muscle responsive artificial lens unit |
US5203790A (en) | 1991-11-12 | 1993-04-20 | Henry H. McDonald | Foldable plastic optical lens with reduced thickness light blocking segments, and anchoring means |
US5203789A (en) | 1991-11-12 | 1993-04-20 | Henry H. McDonald | Foldable plastic optical lens with reduced thickness light blocking segments |
US6423094B1 (en) | 1991-11-18 | 2002-07-23 | Faezeh M. Sarfarazi | Accommodative lens formed from sheet material |
US5275623A (en) | 1991-11-18 | 1994-01-04 | Faezeh Sarfarazi | Elliptical accommodative intraocular lens for small incision surgery |
US6322589B1 (en) | 1995-10-06 | 2001-11-27 | J. Stuart Cumming | Intraocular lenses with fixated haptics |
DE4403326C1 (en) * | 1994-02-03 | 1995-06-22 | Hans Reinhard Prof Dr Koch | Intraocular lens arrangement for astigmatism correction |
ATE272990T1 (en) | 1995-02-15 | 2004-08-15 | Medevec Licensing Bv | ADJUSTABLE INTRAOCULAR LENS WITH T-SHAPED BRACKETS |
US5728155A (en) * | 1996-01-22 | 1998-03-17 | Quantum Solutions, Inc. | Adjustable intraocular lens |
WO1997026842A1 (en) * | 1996-01-26 | 1997-07-31 | Vision Pharmaceuticals L.P. | Primary and supplemental intraocular lens system |
US5769889A (en) * | 1996-09-05 | 1998-06-23 | Kelman; Charles D. | High myopia anterior chamber lens with anti-glare mask |
US5843188A (en) | 1997-10-20 | 1998-12-01 | Henry H. McDonald | Accommodative lens implantation |
SE9800853D0 (en) | 1998-03-16 | 1998-03-16 | Pharmacia & Upjohn Bv | Intraocular lens |
WO2000030246A1 (en) * | 1998-11-16 | 2000-05-25 | Koninklijke Philips Electronics N.V. | Amplifier with stabilization means |
US6197058B1 (en) * | 1999-03-22 | 2001-03-06 | Valdemar Portney | Corrective intraocular lens system and intraocular lenses and lens handling device therefor |
US6488708B2 (en) | 1999-04-09 | 2002-12-03 | Faezeh Sarfarazi | Open chamber, elliptical, accommodative intraocular lens system |
US6406494B1 (en) * | 1999-04-30 | 2002-06-18 | Allergan Sales, Inc. | Moveable intraocular lens |
US6616692B1 (en) * | 1999-04-30 | 2003-09-09 | Advanced Medical Optics, Inc. | Intraocular lens combinations |
US6261321B1 (en) | 1999-09-01 | 2001-07-17 | Robert E. Kellan | Phakic or aphakic intraocular lens assembly |
US6241777B1 (en) | 1999-09-01 | 2001-06-05 | Robert E. Kellan | Phakic intraocular lenses |
US6217612B1 (en) | 1999-09-10 | 2001-04-17 | Randall Woods | Intraocular lens implant having eye accommodating capabilities |
US6299641B1 (en) | 1999-09-10 | 2001-10-09 | Randall Woods | Intraocular lens implant having eye accommodating capabilities |
US6645246B1 (en) | 1999-09-17 | 2003-11-11 | Advanced Medical Optics, Inc. | Intraocular lens with surrounded lens zone |
US6599317B1 (en) | 1999-09-17 | 2003-07-29 | Advanced Medical Optics, Inc. | Intraocular lens with a translational zone |
AU780052B2 (en) | 1999-09-17 | 2005-02-24 | Abbott Gmbh & Co. Kg | Pyrazolopyrimidines as therapeutic agents |
FR2799952B1 (en) | 1999-10-21 | 2001-12-14 | Humanoptics Ag | INTRAOCULAR IMPLANT |
US6767363B1 (en) * | 1999-11-05 | 2004-07-27 | Bausch & Lomb Surgical, Inc. | Accommodating positive and negative intraocular lens system |
US6342073B1 (en) | 1999-12-30 | 2002-01-29 | J. Stuart Cumming | Intraocular lens for posterior vaulting |
FR2804860B1 (en) * | 2000-02-16 | 2002-04-12 | Humanoptics Ag | ACCOMODATIVE CRYSTALLINE IMPLANT |
US6551354B1 (en) | 2000-03-09 | 2003-04-22 | Advanced Medical Optics, Inc. | Accommodating intraocular lens |
US6660035B1 (en) | 2000-08-02 | 2003-12-09 | Advanced Medical Optics, Inc. | Accommodating intraocular lens with suspension structure |
US6558420B2 (en) * | 2000-12-12 | 2003-05-06 | Bausch & Lomb Incorporated | Durable flexible attachment components for accommodating intraocular lens |
US6464725B2 (en) | 2001-01-23 | 2002-10-15 | Bernt Christian Skotton | Two-lens adjustable intraocular lens system |
US6786934B2 (en) | 2001-01-25 | 2004-09-07 | Visiogen, Inc. | Biasing element for intraocular lens system |
US20020120329A1 (en) * | 2001-02-28 | 2002-08-29 | Allergan Sales, Inc. | Moveable intraocular lenses and combinations of intraocular lenses |
AU2002315375A1 (en) * | 2001-06-22 | 2003-01-08 | Ernesto Blanco | An improved accommodating intraocular lens |
US6695881B2 (en) * | 2002-04-29 | 2004-02-24 | Alcon, Inc. | Accommodative intraocular lens |
US6616691B1 (en) * | 2003-01-10 | 2003-09-09 | Alcon, Inc. | Accommodative intraocular lens |
-
2002
- 2002-04-29 US US10/134,877 patent/US6695881B2/en not_active Expired - Lifetime
-
2003
- 2003-03-07 JP JP2004500739A patent/JP4242829B2/en not_active Expired - Fee Related
- 2003-03-07 CA CA002480772A patent/CA2480772C/en not_active Expired - Fee Related
- 2003-03-07 WO PCT/US2003/007249 patent/WO2003092552A1/en active IP Right Grant
- 2003-03-07 AT AT03716423T patent/ATE336966T1/en active
- 2003-03-07 MX MXPA04010096A patent/MXPA04010096A/en active IP Right Grant
- 2003-03-07 BR BR0309586-0A patent/BR0309586A/en not_active IP Right Cessation
- 2003-03-07 AU AU2003220130A patent/AU2003220130B2/en not_active Ceased
- 2003-03-07 DE DE60307816T patent/DE60307816T2/en not_active Expired - Lifetime
- 2003-03-07 DK DK03716423T patent/DK1499264T3/en active
- 2003-03-07 PT PT03716423T patent/PT1499264E/en unknown
- 2003-03-07 ES ES03716423T patent/ES2269998T3/en not_active Expired - Lifetime
- 2003-03-07 EP EP03716423A patent/EP1499264B1/en not_active Expired - Lifetime
- 2003-06-04 US US10/453,995 patent/US6969403B2/en not_active Expired - Lifetime
- 2003-06-04 US US10/453,994 patent/US6926736B2/en not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11357620B1 (en) | 2021-09-10 | 2022-06-14 | California LASIK & Eye, Inc. | Exchangeable optics and therapeutics |
Also Published As
Publication number | Publication date |
---|---|
EP1499264A1 (en) | 2005-01-26 |
JP4242829B2 (en) | 2009-03-25 |
AU2003220130A1 (en) | 2003-11-17 |
DE60307816T2 (en) | 2007-02-22 |
US20030204255A1 (en) | 2003-10-30 |
ATE336966T1 (en) | 2006-09-15 |
JP2006511245A (en) | 2006-04-06 |
US6695881B2 (en) | 2004-02-24 |
US6969403B2 (en) | 2005-11-29 |
US6926736B2 (en) | 2005-08-09 |
ES2269998T3 (en) | 2007-04-01 |
AU2003220130B2 (en) | 2007-07-19 |
EP1499264B1 (en) | 2006-08-23 |
US20030204254A1 (en) | 2003-10-30 |
DK1499264T3 (en) | 2006-12-27 |
BR0309586A (en) | 2005-03-01 |
US20030204256A1 (en) | 2003-10-30 |
PT1499264E (en) | 2007-01-31 |
CA2480772A1 (en) | 2003-11-13 |
WO2003092552A1 (en) | 2003-11-13 |
EP1499264A4 (en) | 2005-08-31 |
MXPA04010096A (en) | 2004-12-13 |
DE60307816D1 (en) | 2006-10-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2480772C (en) | Accommodative intraocular lens | |
CA2510399C (en) | Accommodative intraocular lens | |
CA2585890C (en) | Intraocular lens system | |
US7223288B2 (en) | Accommodative intraocular lens | |
US7029497B2 (en) | Accommodative intraocular lens | |
US7150760B2 (en) | Accommodative intraocular lens system | |
US7316713B2 (en) | Accommodative intraocular lens system | |
AU2008321009B2 (en) | Accommodative intraocular lens system | |
US9078744B2 (en) | Single optic accommodative intraocular lens system | |
US20070016293A1 (en) | Accommodative intraocular lens system | |
US20040249455A1 (en) | Accommodative intraocular lens system |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |
Effective date: 20130307 |